Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–1 of 1 stories
A review highlights the potential of AAV9 vectors in gene therapy for inherited CNS diseases, building on the success of Zolgensma for spinal muscular atrophy. The International Society for Stem Cell Research provides a global map of marketed gene and cell therapies.
Read full storyGet the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.